Effect of loxiglumide on basal and gastrinand bombesin-stimulated gastric acid and serum gastrin levels
- 1 October 1992
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 103 (4) , 1215-1220
- https://doi.org/10.1016/0016-5085(92)91506-y
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in manRegulatory Peptides, 1991
- Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.Journal of Clinical Investigation, 1990
- Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.Journal of Clinical Investigation, 1989
- The effect of loxiglumide (CR-1505) on basal and bombesin-stimulated gallbladder volume in manEuropean Journal of Pharmacology, 1989
- Gastrin receptors on isolated canine parietal cells.Journal of Clinical Investigation, 1984
- Reassessment of Gastric Acid Inhibition by Cyholecystokinin and Gastric Inhibitory Polypeptide in DogsGastroenterology, 1982
- Identification and measurement of molecular variants of cholecystokinin in duodenal mucosa and plasma. Diminished concentrations in patients with celiac disease.Journal of Clinical Investigation, 1982
- Evidence for a common evolutionary origin of gastrin and cholecystokininNature, 1977
- Analysis of inhibition of acid secretion by cholecystokinin in dogsAmerican Journal of Physiology-Legacy Content, 1970
- Gastrin-related peptides as stimulants of pancreatic and gastric secretionAmerican Journal of Physiology-Legacy Content, 1969